Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) fell 7.6% during trading on Wednesday . The company traded as low as $15.33 and last traded at $15.71. 201,252 shares changed hands during trading, a decline of 85% from the average session volume of 1,387,004 shares. The stock had previously closed at $17.00.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on CLMT. Wells Fargo & Company boosted their price objective on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. UBS Group downgraded Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and lowered their price target for the company from $20.50 to $15.00 in a research report on Tuesday, February 4th. HC Wainwright increased their target price on Calumet Specialty Products Partners from $25.00 to $33.00 and gave the company a "buy" rating in a research note on Monday, January 13th. StockNews.com raised Calumet Specialty Products Partners to a "sell" rating in a research report on Monday, November 18th. Finally, TD Cowen reduced their price objective on Calumet Specialty Products Partners from $27.00 to $26.00 and set a "buy" rating for the company in a research report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating and four have given a buy rating to the company's stock. According to data from MarketBeat, Calumet Specialty Products Partners has an average rating of "Hold" and an average price target of $23.60.
Check Out Our Latest Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Price Performance
The firm has a 50 day moving average of $19.83 and a 200-day moving average of $18.91. The stock has a market capitalization of $1.39 billion, a P/E ratio of -5.87 and a beta of 1.88.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.59) by ($0.59). The firm had revenue of $1.10 billion during the quarter, compared to analyst estimates of $888.36 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS. As a group, equities analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current year.
Insiders Place Their Bets
In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the firm's stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total transaction of $810,982.62. Following the completion of the transaction, the director now owns 1,184,589 shares in the company, valued at $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.91% of the company's stock.
Calumet Specialty Products Partners Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.